An international team of researchers has uncovered evidence of partial resistance to artemisinin derivatives — the primary treatment for malaria — in young children with severe malaria.
An international team of neuro-oncology researchers and clinicians has released new recommendations for good clinical practice regarding the use of artificial intelligence methods to more accurately diagnose, monitor and treat brain cancer.
Following a year marked by stronger than expected output and improvement in tackling inflation, the U.S. economy will reach its equilibrium growth rate in 2025 and supply and demand will finally come back into balance after taking major hits during the COVID-19 pandemic, according to an economic forecast from the Indiana University Kelley School of Business.
Researchers at the IU School of Optometry and IU Luddy School of Informatics, Computing and Engineering will advance next-generation technology that uses a simple eye scan to assist in the early detection of conditions such as Alzheimer’s disease, diabetes and heart disease.
Researchers have identified a new genetic marker that could play a role in the development of Alzheimer's disease and lead to novel therapeutic targets and diagnostic tools for the disease.
Researchers have mapped pancreatic cancer tumor ecosystems using tissue from both the primary tumor and metastatic disease. The study uncovers notable differences that could lead to new treatment strategies for the often-deadly disease.
Researchers are studying the brains of a subset of people with asymptomatic Alzheimer's disease who, despite having amyloid plaque and tau buildup postmortem, experienced no diagnosable dementia symptoms while they were living.
Two new papers by an international team of researchers demonstrate that evaluating microRNAs in blood can be used not only to diagnose mild cognitive impairment (MCI) but also to predict the conversion from MCI to dementia due to Alzheimer's disease.
A $7.5 million grant from the U.S. Department of Defense will support research by Indiana University scientist and collaborators across the country into AI’s potential to strengthen the psychological impact of online communications, such as misinformation and radicalizing messages, potentially leading to methods to counteract their influence.
An Indiana University School of Medicine physician scientist is making strides in understanding the molecular origins of fatty liver disease, a leading cause of liver failure in the United States.
The largest study of early-onset Alzheimer's disease in the United States is expanding internationally, becoming one of the largest programs of its kind in the world.
Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have completed the most extensive mapping of healthy breast cells to date. These findings offer an important tool for researchers at IU and beyond to understand how breast cancer develops and the differences in breast tissue among genetic ancestries.
Researchers in linguistics and mathematics are working to adapt the natural language processing algorithms that power AI’s ability to interact with people using normal speech to quantum computers.
Workplace mistreatment results in higher rates of depression and sleep loss in Black employees than white employees according to research from the Indiana University Kelley School of Business in Bloomington.
Indiana University School of Medicine researchers have made a significant breakthrough in developing a new gene therapy approach that restores full-length dystrophin protein, which could lead to new treatments for people with Duchenne muscular dystrophy (DMD).
New research from the Indiana University Kelley School of Business explains how pharmaceutical companies were able to saturate the country with massive quantities of opioids, despite efforts by the Drug Enforcement Administration to regulate their supply.
Indiana University School of Medicine researchers and their collaborators have uncovered molecular insights expected to enhance treatment options for acute myeloid leukemia (AML), a rare and severe blood and bone marrow cancer.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right